This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Zhuhai Essex Bio-Pharmaceutical Co., Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Yingluo Xiong: Innovator in Pharmaceutical Development
Introduction
Yingluo Xiong is a notable inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of recombinant human-basic fibroblast growth factor (rh-bFGF). His work has implications for various medical applications, showcasing his innovative spirit and dedication to advancing healthcare.
Latest Patents
Yingluo Xiong holds 1 patent for his invention titled "Recombinant human-basic fibroblast growth factor (rh-bFGF) and pharmaceutical composition comprising rh-bFGF." This patent provides a mutated nucleic acid molecule of rh-bFGF, a pharmaceutical composition of the rh-bFGF, and outlines its use in medical treatments.
Career Highlights
Xiong is currently associated with Zhuhai Essex Bio-Pharmaceutical Co., Ltd., where he continues to work on groundbreaking pharmaceutical innovations. His expertise in biotechnology and pharmaceuticals has positioned him as a key player in the industry.
Collaborations
Yingluo Xiong has collaborated with notable colleagues, including Xinzhi Wang and Zhenheng Wang. These partnerships have fostered a collaborative environment that enhances research and development efforts in their field.
Conclusion
Yingluo Xiong's contributions to pharmaceutical innovation, particularly through his patent on rh-bFGF, highlight his role as a significant inventor in the industry. His work continues to impact the field of medicine positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile